Legilait

Diosmin, the active ingredient in Legilait, is a flavonoid (phlebotonic/vasoprotective) presented as an oral formulation for oral use. It is employed in the management of chronic venous disease, including chronic venous insufficiency, varicose veins, and hemorrhoidal conditions.

GNH USA supplies Legilait as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality manufacturing and reliable distribution across global markets. The company adheres to stringent regulatory standards and provides comprehensive support for product integration.

Diosmin is used in chronic venous disease to improve venous tone and reduce related symptoms.

Chronic venous insufficiency: improves venous return and lessens leg heaviness, swelling and pain. Varicose veins: reduces vein distension and associated discomfort. Hemorrhoids: alleviates bleeding, itching and swelling of hemorrhoidal tissue.

Common Side Effects: - Gastrointestinal discomfort: mild abdominal pain or dyspepsia. - Nausea: occasional feeling of queasiness. - Headache: transient mild headache. - Dizziness: light‑headed sensation. - Skin rash: mild erythema or itching.

Serious or Rare Side Effects: - Hypersensitivity reactions: urticaria, angioedema or anaphylaxis. - Severe abdominal pain: may indicate intestinal ischemia. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Thrombocytopenia: reduced platelet count leading to bleeding. - Severe allergic reactions: respiratory distress or shock.

Precautions should be considered before initiating therapy with Diosmin.

Pregnancy: safety not established; avoid unless benefits outweigh risks. Breastfeeding: unknown; use with caution. Renal impairment: monitor renal function and adjust if necessary. Drug interactions: review concomitant medications for potential interactions. Store at ambient temperature: keep in the original pack, protect from moisture and light.

Diosmin may interact with several medicines; awareness of potential interactions is important.

Major Interactions (Avoid): - Anticoagulants: may increase bleeding risk. - Corticosteroids: may reduce venotonic efficacy. - Cyclosporine: may raise plasma levels of Diosmin.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase gastrointestinal irritation. - Diuretics: additive effect on fluid balance. - Antihypertensives: may enhance blood pressure lowering.